Picture of Abiomed logo

ABMD Abiomed Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Annual income statement for Abiomed, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5947698418481,032
Cost of Revenue
Gross Profit495640690686844
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses437545596618891
Operating Profit157225245230141
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes160263257288191
Provision for Income Taxes
Net Income After Taxes134259203226137
Net Income Before Extraordinary Items
Extraordinary Items
Net Income112259203226137
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income112259203226137
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.915.614.514.945.18

Or unlock with your email

Or unlock with your email